India oxcarbazepine market is expected to grow at a steady rate during the forecast period. Oxcarbazepine drug is an anticonvulsant used in the treatment of epilepsy. This drug API is either used alone or along with other drugs for treating partial seizures which is expected to rev up the market growth through FY2027. Additionally, supportive government policies and improving healthcare infrastructure are some other reasons that are expected to create lucrative opportunities for the market growth over the next few years.

 

The India oxcarbazepine market is segmented based on source, form, distribution channel, application, end user, company and region. Based on source, the market can be split into in-house and contract manufacturing organizations. Out of which, the in-house segment dominated the market until FY2021 owing to in house production preference by the major market players. The contract manufacturing organizations segment is expected to witness significant growth during the forecast period on account of increased outsourcing activities by the companies in order to focus on their R&D activity and expansion plans. Additionally, contract manufacturing organizations offer competitive pricing and can provide bulk orders in lesser duration. This is further projected to contribute to the segmental growth in the coming years.

 

The major players operating in the India oxcarbazepine market are Sun Pharmaceuticals Industries Ltd., Intas Pharmaceutical Ltd., Sunrise Remedies Pvt. Ltd., Cipla Limited, Zydus Cadila Healthcare Ltd., Nicholas Piramal India Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Consern Pharma Pvt. Ltd., Glenmark Lifesciences Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive Go-to-Market strategies include mergers & acquisitions, research collaborations, customer focus approach and new product developments.

Years considered for this report:

Historical Years: FY2017-FY2020

Base Year: FY2021

Estimated Year: FY2022

Forecast Period: FY2023–FY2027

Objective of the Study:

  • To analyze and estimate the market size of India oxcarbazepine market from FY2017 to FY2020.
  • To estimate and forecast the market size of India oxcarbazepine market from FY2021 to FY2027 and growth rate until FY2027.
  • To classify and forecast India oxcarbazepine market based on source, form, distribution channel, application, end user, company and regional distribution.
  • To identify dominant region or segment in the India oxcarbazepine market.
  • To identify drivers and challenges for India oxcarbazepine market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India oxcarbazepine market.
  • To identify and analyze the profile of leading players operating in India oxcarbazepine market.
  • To identify key sustainable strategies adopted by market players in India oxcarbazepine market. 


Click here to download the sample


TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India oxcarbazepine market using bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research. 

Key Target Audience:

  • Oxcarbazepine manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to oxcarbazepine

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India oxcarbazepine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Oxcarbazepine Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Oxcarbazepine Market, By Form:
    • Tablet
    • Oral Suspension
  • India Oxcarbazepine Market, By Distribution Channel:
    • Online
    • Offline
  • India Oxcarbazepine Market, By Application:
    • Epilepsy
    • Neuropathic Pain
    • Seizures
    • Others
  • India Oxcarbazepine Market, By End User:
    • Adult
    • Paediatric
  • India Oxcarbazepine Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India oxcarbazepine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India oxcarbazepine market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Oxcarbazepine Market

4.    Executive Summary

5.    Manufacturing Oxcarbazepine

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Oxcarbazepine

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Oxcarbazepine Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.2.     By Form (Tablet v/s Oral Suspension)

7.2.3.     By Distribution Channel (Online v/s Offline)

7.2.4.     By Application (Epilepsy, Neuropathic Pain, Seizures and Others)

7.2.5.     By End User (Adult v/s Paediatric)

7.2.6.     By Region (North, East, South, West)

7.2.7.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Sun Pharmaceuticals Industries Ltd.

14.1.1.1.      Company Brief

14.1.1.2.      Production Plants & Capacity (If Available)

14.1.1.3.      Financials (If Available)

14.1.1.4.      Captive Consumption Vs Merchant Sale

14.1.1.5.      Current & Future Plans

14.1.2.  Intas Pharmaceutical Ltd.

14.1.3.  Sunrise Remedies Pvt. Ltd.

14.1.4.  Cipla Limited

14.1.5.  Zydus Cadila Healthcare Ltd.

14.1.6.  Nicholas Piramal India Ltd.

14.1.7.  Torrent Pharmaceuticals Ltd.

14.1.8.  Macleods Pharmaceuticals Ltd.

14.1.9.  Consern Pharma Pvt. Ltd.

14.1.10.                Glenmark Lifesciences Ltd.

15.  Strategic Recommendations

 16.     About Us & Disclaimer